Landmark Trials in Heart Failure

Several landmark clinical trials have significantly influenced the management and understanding of heart failure over the years. These trials have provided crucial evidence for the efficacy and safety of various treatment strategies. Here are some notable landmark trials:

SOLVD (Studies of Left Ventricular Dysfunction): SOLVD demonstrated the benefits of angiotensin-converting enzyme (ACE) inhibitors in reducing mortality and hospitalizations in patients with heart failure and reduced ejection fraction.

MERIT-HF (Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure): This trial highlighted the benefits of beta-blockers, specifically metoprolol, in improving survival and reducing hospitalizations in patients with heart failure and reduced ejection fraction.

CIBIS (Cardiac Insufficiency Bisoprolol Study) and COPERNICUS (Carvedilol Prospective Randomized Cumulative Survival): These trials demonstrated the benefits of beta-blockers (bisoprolol and carvedilol, respectively) in reducing mortality and hospitalizations in heart failure patients.

EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure): This trial showed that adding the mineralocorticoid receptor antagonist eplerenone to standard therapy reduced the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure and reduced ejection fraction.

PARADIGM-HF (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure): This trial demonstrated the superiority of angiotensin receptor-neprilysin inhibitor (ARNI) over ACE inhibitors in reducing mortality and hospitalizations in heart failure patients with reduced ejection fraction.

These landmark trials have shaped current heart failure treatment guidelines and have significantly improved outcomes for patients with heart failure, providing evidence-based strategies that have become the standard of care.

    Related Conference of Landmark Trials in Heart Failure

    August 08-09, 2024

    13th World Heart Congress

    London, UK
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    September 19-20, 2024

    6th Annual Conference on Vascular Medicine

    London, UK
    September 19-20, 2024

    7th World Heart and Brain Conference

    London, UK
    October 17-18, 2024

    38th World Congress on Heart Diseases

    London, UK
    October 17-18, 2024

    3rd International Conference on Cardiology

    London, UK
    October 17-18, 2024

    8th Annual Heart Rhythm Conference

    Barcelona, Spain
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    December 10-11, 2024

    6th Euro Cardiology Congress

    Dubai, UAE
    December 26-27, 2024

    28th World Cardiology Conference

    Aix-en-Provence, France
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy

    Landmark Trials in Heart Failure Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in